Siemens DCA™ Systems Microalbumin/Creatinine - HSA Registration DE0012499
Access comprehensive regulatory information for Siemens DCA™ Systems Microalbumin/Creatinine in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0012499 and owned by Simens Healthcare Diagnostics Inc.. The device was registered on March 04, 2013.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The DCA Microalbumin/Creatinine assay is a convenient, quantitative method for measuring low concentrations of albumin, creatinine, and the albumin/creatinine ratio in urine. The method is designed for decentralized testing using random, overnight, or timed specimens with results available to the patient within seven minutes. Testing for microalbuminuria (low concentrations of albumin in the urine) is recommended in patients with insulin-dependent diabetes mellitus (IDDM) as well as patients with non-insulin-dependent diabetes mellitus (NIDDM).This assay is intended for use in both screening for, and monitoring treatment of, microalbuminuria.